Dietary guidelines and health—is nutrition science up to the task?

Despite criticism and controversy, nutrition science can be relied on to improve our understanding of food and health, argue Dariush Mozaffarian and Nita Forouhi

[1]  N. Board. Redesigning the Process for Establishing the Dietary Guidelines for Americans , 2017 .

[2]  N. Board. Optimizing the Process for Establishing the Dietary Guidelines for Americans: The Selection Process , 2017 .

[3]  L. Bero Developing reliable dietary guidelines , 2017, British Medical Journal.

[4]  T. Frieden Evidence for Health Decision Making — Beyond Randomized, Controlled Trials: The Changing Face of Clinical Trials , 2017, The New England journal of medicine.

[5]  D. Mozaffarian Conflict of Interest and the Role of the Food Industry in Nutrition Research. , 2017, JAMA.

[6]  D. Mozaffarian,et al.  Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States , 2017, JAMA.

[7]  Jessica Tran,et al.  Do Sugar-Sweetened Beverages Cause Obesity and Diabetes? Industry and the Manufacture of Scientific Controversy , 2016, Annals of Internal Medicine.

[8]  L. Bero,et al.  Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. , 2016, JAMA internal medicine.

[9]  L. Bero,et al.  Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews , 2016, PloS one.

[10]  D. Mozaffarian,et al.  Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials , 2016, PLoS medicine.

[11]  D. van der A,et al.  Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study , 2016, PLoS medicine.

[12]  D. Mozaffarian,et al.  ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. , 2016, JAMA internal medicine.

[13]  D. Yach,et al.  Should we welcome food industry funding of public health research? , 2016, British Medical Journal.

[14]  S. Nissen U.S. Dietary Guidelines: An Evidence-Free Zone , 2016, Annals of Internal Medicine.

[15]  D. Mozaffarian Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[16]  Xinyan Jiang,et al.  Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials , 2015, Menopause.

[17]  V. Montori,et al.  Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. , 2015, The Journal of clinical endocrinology and metabolism.

[18]  M. Nestle Soda Politics: Taking on Big Soda (and Winning) , 2015 .

[19]  D. Mozaffarian,et al.  The 2015 US Dietary Guidelines: Lifting the Ban on Total Dietary Fat. , 2015, JAMA.

[20]  Andrew A. Toole,et al.  Federal Support for Nutrition Research Trends Upward as USDA Share Declines , 2015 .

[21]  Anne Eisinga,et al.  Hormone therapy for preventing cardiovascular disease in post-menopausal women. , 2015, The Cochrane database of systematic reviews.

[22]  J. Merino,et al.  Exclusion of ‘nonRCT evidence’ in guidelines for chronic diseases – is it always appropriate? The Look AHEAD study , 2014, Current medical research and opinion.

[23]  L. Bero,et al.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. , 2014, The Cochrane database of systematic reviews.

[24]  M. Schulze,et al.  Financial Conflicts of Interest and Reporting Bias Regarding the Association between Sugar-Sweetened Beverages and Weight Gain: A Systematic Review of Systematic Reviews , 2013, PLoS medicine.

[25]  J. Ioannidis Implausible results in human nutrition research , 2013, BMJ.

[26]  D. Mozaffarian,et al.  Mediterranean diet for primary prevention of cardiovascular disease. , 2013, The New England journal of medicine.

[27]  Sergio Sismondo,et al.  Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.

[28]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[29]  D. Mozaffarian,et al.  Components of a Cardioprotective Diet: New Insights , 2011, Circulation.

[30]  Douglas P. Zipes,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .

[31]  P. Libby,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[32]  D. Mozaffarian,et al.  Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.

[33]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[34]  R. Mensink,et al.  Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.

[35]  Heidi D Nelson,et al.  Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.

[36]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[37]  D R Jacobs,et al.  Reductionism and the narrowing nutrition perspective: time for reevaluation and emphasis on food synergy. , 2001, Journal of the American Dietetic Association.

[38]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[39]  N. Wintfeld,et al.  Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.

[40]  G. Colditz,et al.  Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. , 1993, American journal of obstetrics and gynecology.

[41]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.